Wolff Wiese Magana’s Takeda Pharmaceutical TAK Stock Holding History

Wolff Wiese Magana’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-390	Closed	-$5K	–	959
2022 Q3	$5K	Sell	390 -619	-61%	-$8.61K	﹤0.01%	624
2022 Q2	$14K	Hold	1,009	–	–	0.01%	484
2022 Q1	$14K	Hold	1,009	–	–	0.01%	496
2021 Q4	$14K	Sell	1,009 -383	-28%	-$5.37K	0.01%	490
2021 Q3	$23K	Buy	1,392 +390	+39%	+$6.55K	0.02%	403
2021 Q2	$17K	Buy	1,002 +100	+11%	+$1.7K	0.01%	423
2021 Q1	$16K	Buy	902 +73	+9%	+$1.31K	0.01%	421
2020 Q4	$15K	Buy	+829	New	+$14.5K	0.01%	401

Other funds holding TAK

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wolff Wiese Magana's TAK Position: Q4 2022 in Review

Wolff Wiese Magana sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 390 shares — an estimated $5K sold.

Wolff Wiese Magana first reported a position in TAK in Q4 2020 and held it in 8 quarters. The position peaked at $23K in Q3 2021. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

Wolff Wiese Magana reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
Wolff Wiese Magana sold 390 Takeda Pharmaceutical shares in Q4 2022, an estimated $5K.
Wolff Wiese Magana first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 8 quarters.
Wolff Wiese Magana's Takeda Pharmaceutical position peaked at $23K in Q3 2021.
281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Wolff Wiese Magana's 13F filing for Q4 2022, filed 9 Feb 2023.